New Reports Provides 15-year Forecast of Japan’s Pharmaceutical Market

Dec. 3, 2008 - PRLog -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report offering a detailed guide to Japan’s pharmaceutical market.

“The Japanese Pharmaceutical Market 2008-2023”, available at http://preview.tinyurl.com/6bf5q8 reports that despite being the second largest pharmaceutical market in 2007, with a value of $58.5 billion, Japan's pharmaceutical market has recently experienced a lower growth rate than any of the major pharmaceutical markets. The slow growth is a result of the government’s stringent pricing and reimbursement policy.

According to the 123-page report, the Japanese pharmaceutical market will see an increasing number of mergers and overall consolidation. The key factor in deciding whether or not a global pharmaceutical company will look to buy out a smaller Japanese company is likely to be the strength of the pipeline of the target company. Global pharmaceutical companies, such as Pfizer, are already establishing a major presence in Japan.

Through a comprehensive review of key information and sources, including interviews, industrial databases, commercial news and in-house reports, the report examines the leading market critically. Furthermore, the analysis applies financial forecasting, qualitative analyses and an assessment of unmet needs to provide a detailed market report with detailed analysis and informed opinion.

Key information in the report includes:
•   Discussion of the current Japanese pharmaceutical market in the context of
•   the global pharma market
•   Forecast of the overall Japanese pharmaceutical market from 2008 to 2023
•   Drivers and restraints facing the Japanese market
•   Opportunities and threats facing the Japanese market
•   Commercial prospects for the market-leading drugs, with sales forecasts
from 2008 to 2023
•   Individual forecasts of the leading drug classes from 2008 to 2023
•   The potential of generics manufacturers to penetrate this market
•   Relevant pipeline developments with blockbuster potential
•   Currently marketed drugs with blockbuster potential
•   Discussion of unmet therapeutic needs

The report “The Japanese Pharmaceutical Market 2008-2023” is available from Piribo. For further information, please visit:  
http://www.piribo.com/publications/country/asia_pacific/j...

Piribo product ID: VIS084

# # #

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 10,000 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.